Found: 10
Select item for more details and to access through your institution.
Proposed best practice for projects that involve modelling and simulation.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 2, p. 107, doi. 10.1002/pst.1789
- By:
- Publication type:
- Article
Robust inference for group sequential trials.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 2, p. 167, doi. 10.1002/pst.1800
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 2, p. 97, doi. 10.1002/pst.1782
- Publication type:
- Article
Statistical issues in first-in-human studies on BIA 10-2474: Neglected comparison of protocol against practice.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 2, p. 100, doi. 10.1002/pst.1801
- By:
- Publication type:
- Article
Addressing potential prior-data conflict when using informative priors in proof-of-concept studies.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 2, p. 174, doi. 10.1002/pst.1802
- By:
- Publication type:
- Article
Application of Bayesian hierarchical models for phase I/II clinical trials in oncology.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 2, p. 114, doi. 10.1002/pst.1793
- By:
- Publication type:
- Article
A simulation study of methods for selecting subgroup-specific doses in phase 1 trials.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 2, p. 143, doi. 10.1002/pst.1797
- By:
- Publication type:
- Article
Model averaging for treatment effect estimation in subgroups.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 2, p. 133, doi. 10.1002/pst.1796
- By:
- Publication type:
- Article
Α Markov model for longitudinal studies with incomplete dichotomous outcomes.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 2, p. 122, doi. 10.1002/pst.1794
- By:
- Publication type:
- Article
Analyzing multiple endpoints in a confirmatory randomized clinical trial-an approach that addresses stratification, missing values, baseline imbalance and multiplicity for strictly ordinal outcomes.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 2, p. 157, doi. 10.1002/pst.1799
- By:
- Publication type:
- Article